Erkmen, T. And Erkmen, T. 2019. CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4 , 438-451.

Erkmen, T., & Erkmen, T., (2019). CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, 438-451.

Erkmen, TUĞBA, And Tuğba Erkmen. "CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor," TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, 438-451, 2019

Erkmen, TUĞBA E. And Erkmen, Tuğba. "CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor." TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.438-451, 2019

Erkmen, T. And Erkmen, T. (2019) . "CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor." TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.438-451.

@article{article, author={TUĞBA ERKMEN DOĞRU And author={Tuğba Erkmen}, title={CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor}, journal={TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI}, year=2019, pages={438-451} }